Clinical Trial Update: An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)

View source ↗

Summary

An observational study evaluating outcomes in patients with rheumatoid arthritis treated with MabThera (rituximab) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED